[HTML][HTML] Lipid nanoparticles as delivery vehicles for inhaled therapeutics
EWX Leong, R Ge - Biomedicines, 2022 - mdpi.com
Lipid nanoparticles (LNPs) have emerged as a powerful non-viral carrier for drug delivery.
With the prevalence of respiratory diseases, particularly highlighted by the current COVID-19 …
With the prevalence of respiratory diseases, particularly highlighted by the current COVID-19 …
Nanoparticle-based drug delivery system: the magic bullet for the treatment of chronic pulmonary diseases
S Pramanik, S Mohanto, R Manne… - Molecular …, 2021 - ACS Publications
Chronic pulmonary diseases encompass different persistent and lethal diseases, including
chronic obstructive pulmonary disease (COPD), idiopathic pulmonary fibrosis (IPF), cystic …
chronic obstructive pulmonary disease (COPD), idiopathic pulmonary fibrosis (IPF), cystic …
Solid lipid nanoparticles for targeted natural and synthetic drugs delivery in high-incidence cancers, and other diseases: Roles of preparation methods, lipid …
Solid lipid nanoparticles (SLNs), the spheroidal-shaped, colloids state lipophilic-natured,
innovative nanoscale particulate materials, are being concurrently prepared by the quality …
innovative nanoscale particulate materials, are being concurrently prepared by the quality …
Inhalable nanoparticle-based dry powder formulations for respiratory diseases: challenges and strategies for translational research
The emergence of novel respiratory infections (eg, COVID-19) and expeditious development
of nanoparticle-based COVID-19 vaccines have recently reignited considerable interest in …
of nanoparticle-based COVID-19 vaccines have recently reignited considerable interest in …
Progress of gelatin-based microspheres (GMSs) as delivery vehicles of drug and cell
Z Dong, X Meng, W Yang, J Zhang, P Sun… - Materials Science and …, 2021 - Elsevier
Gelatin has various attractive features as biomedical materials, for instance, biocompatibility,
low immunogenicity, biodegradability, and ease of manipulation. In recent years, various …
low immunogenicity, biodegradability, and ease of manipulation. In recent years, various …
[HTML][HTML] Solid lipid nanoparticles
Definition Solid lipid nanoparticles (SLNs) are produced from physiologically biocompatible
lipids. They have been proven to improve solubility, cellular uptake, and stability, reduce …
lipids. They have been proven to improve solubility, cellular uptake, and stability, reduce …
Gefitinib: an updated review of its role in the cancer management, its nanotechnological interventions, recent patents and clinical trials
Background: Gefitinib, a tyrosine kinase inhibitor, is effectively used in the targeted treatment
of malignant conditions. It suppresses the signal transduction cascades leading to cell …
of malignant conditions. It suppresses the signal transduction cascades leading to cell …
[HTML][HTML] Development of a new inhaled swellable microsphere system for the dual delivery of naringenin-loaded solid lipid nanoparticles and doxofylline for the …
A Pareek, R Kothari, A Pareek, Y Ratan… - European Journal of …, 2024 - Elsevier
This study developed a new dual delivery system of naringenin (NRG), a polyphenol, and
doxofylline (DOX), a xanthine derivative, as an inhaled microsphere system. In this system …
doxofylline (DOX), a xanthine derivative, as an inhaled microsphere system. In this system …
Evaluation of thermosensitive chitosan hydrogel containing gefitinib loaded cellulose acetate butyrate nanoparticles in a subcutaneous breast cancer model
In the present study, gefitinib loaded cellulose acetate butyrate nanoparticles (Gnb-NPs)
were prepared and then incorporated into thermo-sensitive chitosan/β-glycerophosphate …
were prepared and then incorporated into thermo-sensitive chitosan/β-glycerophosphate …
A nanotechnology driven effectual localized lung cancer targeting approaches using tyrosine kinases inhibitors: Recent progress, preclinical assessment, challenges …
The higher incidence and mortality rate among all populations worldwide explains the
unmet solutions in the treatment of lung cancer. The evolution of targeted therapies using …
unmet solutions in the treatment of lung cancer. The evolution of targeted therapies using …